Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Illumina (GB:0J8Z)
LSE:0J8Z
Illumina (0J8Z) Share Price & Analysis
0 Followers
0J8Z Stock Chart & Stats
Day’s Range$122.19 - $126.25
52-Week Range― - ―
Previous Close$123.36
Volume2.17K
Average Volume (3M)N/A
Market Cap
$19.81B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Aug 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$151.18Price Target Upside21.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Illumina News
PremiumCompany Announcements
Illumina Gains Approval for GRAIL Divestiture Plans
Bulls Say, Bears Say
Bulls Say
Product Demand And Market ExpansionNovaSeq X systems shipments exceeded initial guidance, indicating strong product demand.
Regulatory ApprovalThe EU approved ILMN's divestiture plan, providing a clear path forward.
Strategic Financial PlanningManagement expects to issue debt over equity if a capital markets transaction occurs, indicating confidence in financial strategy.
Bears Say
Financial GuidanceBacklog at the end of FY23 is now down to $653mn, sharply lower compared to FY22 ending backlog.
Management StabilityILMN has seen the departure of multiple top executives in the past year, which raises concerns about corporate stability.
Market CompetitionILMN is facing a number of headwinds including a tough macro backdrop, geopolitical risks to China revenues, GRAIL divestiture, and increased competition.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.81% Insiders
31.32% Mutual Funds
36.66% Other Institutional Investors
30.21% Public Companies and
Individual Investors
0J8Z FAQ
What was Illumina’s price range in the past 12 months?
Currently, no data Available
What is Illumina’s market cap?
Currently, no data Available
When is Illumina’s upcoming earnings report date?
Illumina’s upcoming earnings report date is Aug 08, 2024 which is in 97 days.
How were Illumina’s earnings last quarter?
Illumina released its earnings results on May 02, 2024. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.047.
Is Illumina overvalued?
According to Wall Street analysts Illumina’s price is currently Undervalued.
Does Illumina pay dividends?
Illumina does not currently pay dividends.
What is Illumina’s EPS estimate?
Illumina’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Illumina have?
Currently, no data Available
What happened to Illumina’s price movement after its last earnings report?
Illumina reported an EPS of $0.09 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -4.38%.
Which hedge fund is a major shareholder of Illumina?
Among the largest hedge funds holding Illumina’s share is Guardcap Asset Management Ltd. It holds Illumina’s shares valued at 285M.
---
Illumina Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$151.18 (21.45% Upside)
$151.18 (21.45% Upside)
Blogger Sentiment
Bullish
GB:0J8Z Sentiment 76%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $991.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.46%
12-Months-Change
Fundamentals
Return on Equity
-20.76%
Trailing 12-Months
Asset Growth
-14.99%
Trailing 12-Months
Company Description
Illumina
Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.
---
0J8Z Company Deck
---
0J8Z Earnings Call
Q1 2024
0:00 / 0:00
---
0J8Z Revenue Breakdown
68.45% Consumables
15.92% Service and other revenue
15.63% Instruments
---
0J8Z Stock 12 Months Forecast
Average Price Target
$151.18
▲(21.45% Upside)
Technical Analysis
Best Analysts Covering 0J8Z
1 Year
1 Year Success Rate
16/20 ratings generated profit
1 Year Average Return
+14.31%
reiterated a sell rating 24 days ago
Copying Luke Sergott's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +14.31% per trade.
---